From the Field · a newsletter from AgifyMD

What actually works in sales, tested on real accounts.

Every other Tuesday, Mayeul, founder of AgifyMD, breaks down one AI-assisted sales method: what worked, what didn’t, and a template to run it yourself, with examples from selling to healthcare facilities. It comes out in French first, with an English edition to follow.

  • Under five minutes to read
  • One method per issue, plus a template to copy into your own tools
  • Concrete cases, including what failed as well as what worked
  • Written by the host of IA Mastery, a community of 10,700 members
  • Issues dedicated to MedTech: conferences, public tenders, hospital departments
  • Free, no ads, one-click unsubscribe
  • 130+ salespeople equipped
  • Backed by Station F

Issues

Read before you subscribe

Sample issues, written to show the tone and format. The newsletter hasn’t gone out yet: this is what each issue will look like.

Who writes it

Methods tested before they’re written up.

Mayeul RougevinFounder and CEO

Mayeul founded AgifyMD, which helps MedTech sales teams spot the healthcare facilities with a reason to buy now, find the decision-maker, and reach out at the right moment. Every week, he works with sales teams on their own accounts, inside their own tools.

From the Field is what comes out of that work: what holds up on real accounts, what doesn’t, and why. He also runs the IA Mastery community, where professionals learn to work with AI.

  • 10,700 IA Mastery members

One idea, one case, one template to copy.

The story

One concrete case, told straight: what we expected, what happened, what we learned. One idea per issue, never a news roundup.

The template

A tracker, a prompt, or a checklist you can drop into your own tools the very next day.

Seen in the field

A short observation from a call or a campaign that fits in three sentences.

The question

Every issue ends with a question. Just hit reply. We only publish an answer with its author’s permission.

FAQ

Before you subscribe

The next issue, straight to your inbox.

One sales method tested on real accounts, every other Tuesday. Under five minutes to read, no ads.